Pfizer sweeps out a lineup of neuroscience drugs — as well as cancer and NASH programs — into the scrap heap
Anyone shopping for some early- and mid-stage neurosciences programs should look over the menu of discontinued programs out from Pfizer $PFE this morning. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
